The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Prof Gladyshev and team developed transcriptomic clocks that don’t just estimate age, they measure the progressive loss of cellular function and predict biological decline and mortality risk across mammals. That is a major advance because it brings us closer to measuring the underlying process of aging itself, not just the passage of time, in a way first shown by Prof. Steven Horvath in 2013.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.